Bancreek US Large Cap ETF (NYSEARCA:BCUS) Sees Significant Increase in Short Interest

Bancreek US Large Cap ETF (NYSEARCA:BCUSGet Free Report) was the target of a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 2,394 shares, a growth of 185.7% from the May 14th total of 838 shares. Based on an average daily volume of 5,431 shares, the short-interest ratio is currently 0.4 days. Approximately 0.1% of the shares of the company are sold short.

Hedge Funds Weigh In On Bancreek US Large Cap ETF

A hedge fund recently bought a new stake in Bancreek US Large Cap ETF stock. JPMorgan Chase & Co. acquired a new stake in Bancreek US Large Cap ETF (NYSEARCA:BCUSFree Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 867 shares of the company’s stock, valued at approximately $28,000.

Bancreek US Large Cap ETF Stock Up 0.6%

NYSEARCA:BCUS traded up $0.22 during mid-day trading on Friday, hitting $36.37. 4,394 shares of the company traded hands, compared to its average volume of 21,462. The stock’s fifty day moving average price is $34.94 and its 200-day moving average price is $33.48. Bancreek US Large Cap ETF has a one year low of $30.41 and a one year high of $36.55. The firm has a market cap of $109.84 million, a price-to-earnings ratio of 29.33 and a beta of 0.86.

About Bancreek US Large Cap ETF

(Get Free Report)

The Bancreek U.S. Large Cap ETF (BCUS) is an exchange-traded fund that mostly invests in large cap equity. The fund is an actively managed fund that invests in US large-cap companies the sub-adviser believes exhibit structurally advantaged business models. BCUS was launched on Dec 20, 2023 and is issued by Bancreek.

Read More

Receive News & Ratings for Bancreek US Large Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bancreek US Large Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.